Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit

14:10 EDT 29 May 2018 | Cancer Connect

The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients […]

More From BioPortfolio on "Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit"